Carisma Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-86.88	-61.23	-0.34	-22.54	-107.5	-33.69	-29.03	1.89	-33.45	-34.68	Upgrade
Depreciation & Amortization	8.27	6.09	0.09	0.12	0.22	0.21	0.29	0.18	0.37	0.41	Upgrade
Share-Based Compensation	2.32	0.28	5.14	1.76	1.24	1.28	1.38	4.01	2.53	2.43	Upgrade
Other Operating Activities	-4.88	49.75	-73.77	-10.32	68.52	9.37	9.6	-3.54	-3.97	2.01	Upgrade
Operating Cash Flow	-81.18	-5.12	-68.88	-30.84	-37.52	-22.83	-17.77	2.54	-34.53	-29.31	Upgrade
Capital Expenditures	-1.13	-4.66	-0	-0.01	-0.14	-0	0.1	0.33	-0.29	-0.14	Upgrade
Acquisitions	0	0	0	0	0	0	0	0.14	0	0	Upgrade
Change in Investments	73.54	-27.9	0	0	0	0	0	0	0	0	Upgrade
Investing Cash Flow	72.41	-32.56	-0	-0.01	-0.14	-0	0.1	0.46	-0.29	-0.14	Upgrade
Share Issuance / Repurchase	31.42	0.11	176.13	38.1	35.35	58.58	7.01	0.27	12.71	70.31	Upgrade
Debt Issued / Paid	-1.33	33.21	0	0	0	0	0	-14.12	4.12	5.25	Upgrade
Other Financing Activities	32.09	-	-0	0.01	0.01	-	-	0.04	-	-	Upgrade
Financing Cash Flow	62.18	33.32	176.13	38.11	35.36	58.58	7.01	-13.82	16.84	75.56	Upgrade
Net Cash Flow	53.41	-4.36	107.25	7.27	-2.3	35.75	-10.66	-10.82	-17.98	46.12	Upgrade
Free Cash Flow	-82.31	-9.78	-68.88	-30.85	-37.66	-22.83	-17.67	2.86	-34.82	-29.44	Upgrade
Free Cash Flow Margin	-551.71%	-99.41%	-259.50%	-274.52%	-	-	-4156.94%	9.55%	-3516.77%	-1312.71%	Upgrade
Free Cash Flow Per Share	-2.46	-4.59	-7.56	-5.22	-8.28	-7.39	-13.54	2.72	-36.66	-40.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).